{
    "Trade/Device Name(s)": [
        "cobas\u00ae CT/NG v2.0 Test"
    ],
    "Submitter Information": "Roche Molecular Systems, Inc.",
    "510(k) Number": "K132270",
    "Predicate Device Reference 510(k) Number(s)": [
        "K110923"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MKZ",
        "LSL",
        "O0I"
    ],
    "Summary Letter Date": "November 8, 2013",
    "Summary Letter Received Date": "November 12, 2013",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3120",
        "21 CFR 866.3390",
        "21 CFR 862.2570"
    ],
    "Regulation Name(s)": [
        "Chlamydia serological reagents",
        "Neisseria spp. direct serological test reagents",
        "Real Time Nucleic Acid Amplification System"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology"
    ],
    "Analyte(s)": [
        "Chlamydia trachomatis (CT) DNA",
        "Neisseria gonorrhoeae (NG) DNA"
    ],
    "Specimen Type(s)": [
        "Male urine",
        "Female urine",
        "Self-collected vaginal swab",
        "Clinician-collected vaginal swab",
        "Endocervical swab",
        "Cervical specimen in PreservCyt solution"
    ],
    "Specimen Container(s)": [
        "cobas PCR Media",
        "PreservCyt solution"
    ],
    "Instrument(s)/Platform(s)": [
        "cobas\u00ae 4800 System",
        "cobas x 480 Instrument",
        "cobas z 480 Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Nucleic acid amplification",
        "Polymerase Chain Reaction (PCR)",
        "Real-time PCR"
    ],
    "Methodologies": [
        "Qualitative detection",
        "Nucleic acid amplification testing",
        "PCR amplification",
        "Real-time detection"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay",
        "Reagent",
        "Kit",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for cobas CT/NG v2.0 Test, an automated real-time PCR assay for qualitative detection of Chlamydia trachomatis and Neisseria gonorrhoeae DNA in urogenital specimens",
    "Indications for Use Summary": "Automated in vitro nucleic acid amplification test for qualitative detection of Chlamydia trachomatis and/or Neisseria gonorrhoeae DNA in male and female urine, vaginal, endocervical, and cervical (PreservCyt) specimens as an aid in diagnosis of chlamydial and gonococcal disease in symptomatic or asymptomatic individuals.",
    "fda_folder": "Microbiology"
}